Cardillo TM - Search Results

1

Antibody-Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release.

Kopp A, Hofsess S, Cardillo TM, Govindan SV, Donnell J, Thurber GM. Kopp A, et al. Among authors: cardillo tm. Mol Cancer Ther. 2023 Jan 3;22(1):102-111. doi: 10.1158/1535-7163.MCT-22-0375. Mol Cancer Ther. 2023. PMID: 36190986 Free PMC article.

2

Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.

Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, Goldenberg DM. Sapra P, et al. Among authors: cardillo tm. Clin Cancer Res. 2005 Jul 15;11(14):5257-64. doi: 10.1158/1078-0432.CCR-05-0204. Clin Cancer Res. 2005. PMID: 16033844

3

CD74: a new candidate target for the immunotherapy of B-cell neoplasms.

Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM. Stein R, et al. Among authors: cardillo tm. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5556s-5563s. doi: 10.1158/1078-0432.CCR-07-1167. Clin Cancer Res. 2007. PMID: 17875789 Review.

4

Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy.

Moon SJ, Govindan SV, Cardillo TM, D'Souza CA, Hansen HJ, Goldenberg DM. Moon SJ, et al. Among authors: cardillo tm. J Med Chem. 2008 Nov 13;51(21):6916-26. doi: 10.1021/jm800719t. Epub 2008 Oct 22. J Med Chem. 2008. PMID: 18939816 Free PMC article.

5

CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.

Govindan SV, Cardillo TM, Moon SJ, Hansen HJ, Goldenberg DM. Govindan SV, et al. Among authors: cardillo tm. Clin Cancer Res. 2009 Oct 1;15(19):6052-61. doi: 10.1158/1078-0432.CCR-09-0586. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789330 Free PMC article.

6

Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cells.

Chang CH, Gupta P, Michel R, Loo M, Wang Y, Cardillo TM, Goldenberg DM. Chang CH, et al. Among authors: cardillo tm. Mol Cancer Ther. 2010 Aug;9(8):2276-86. doi: 10.1158/1535-7163.MCT-10-0338. Epub 2010 Jul 27. Mol Cancer Ther. 2010. PMID: 20663928

7

Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys.

Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Goldenberg DM. Cardillo TM, et al. Clin Cancer Res. 2011 May 15;17(10):3157-69. doi: 10.1158/1078-0432.CCR-10-2939. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372224 Free PMC article.

8

Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies.

Sharkey RM, Govindan SV, Cardillo TM, Goldenberg DM. Sharkey RM, et al. Among authors: cardillo tm. Mol Cancer Ther. 2012 Jan;11(1):224-34. doi: 10.1158/1535-7163.MCT-11-0632. Epub 2011 Oct 28. Mol Cancer Ther. 2012. PMID: 22039078

9

Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancers.

Govindan SV, Cardillo TM, Sharkey RM, Tat F, Gold DV, Goldenberg DM. Govindan SV, et al. Among authors: cardillo tm. Mol Cancer Ther. 2013 Jun;12(6):968-78. doi: 10.1158/1535-7163.MCT-12-1170. Epub 2013 Feb 20. Mol Cancer Ther. 2013. PMID: 23427296

10

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer.

Liu D, Cardillo TM, Wang Y, Rossi EA, Goldenberg DM, Chang CH. Liu D, et al. Among authors: cardillo tm. Mol Cancer. 2014 Mar 10;13:53. doi: 10.1186/1476-4598-13-53. Mol Cancer. 2014. PMID: 24606732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters